Brief: Onxeo Q1 revenue down at 782,000 euro
April 28 (Reuters) - Onxeo SA C4X.PA :
* Q1 revenue of 782,000 euro versus 918,000 euro ($1.04
million)
* As of March 31, 2016, consolidated cash position amounted
to 24.4 million euro, in line with expectations
Source text for Eikon: urn:newsml:reuters.com:*:nBw25fNhVa
Further company coverage: C4X.PA
($1 = 0.8821 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln